Cranbrook Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$305K Hold
585
– – 0.06% 113
2026
Q2
$308K Sell
585
-26
-4% -$14.6K 0.06% 110
2026
Q1
$343K Hold
611
– – 0.07% 100
2025
Q4
$413K Buy
611
+240
+65% +$163K 0.08% 92
2025
Q3
$237K Hold
371
– – 0.05% 120
2025
Q2
$199K Hold
371
– – 0.04% 118
2025
Q1
$156K Sell
371
-11
-3% -$4.78K 0.04% 123
2024
Q4
$158K Buy
382
+25
+7% +$11K 0.04% 123
2024
Q3
$180K Hold
357
– – 0.04% 116
2024
Q2
$174K Buy
+357
New +$179K 0.04% 114

Other funds holding IDXX

Cranbrook Wealth Management's IDXX Position: Q3 2026 in Review

Cranbrook Wealth Management held its Idexx Laboratories (IDXX) position steady in Q3 2026 at 585 shares worth $305K. The position accounts for 0.06% of the portfolio, ranked #113.

Cranbrook Wealth Management first reported a position in IDXX in Q2 2024 and has held it in 10 quarters since. The position peaked at $413K in Q4 2025. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Cranbrook Wealth Management held 585 shares of Idexx Laboratories worth $305K as of Q3 2026.
  • Cranbrook Wealth Management left its Idexx Laboratories share count unchanged in Q3 2026.
  • Idexx Laboratories made up 0.06% of Cranbrook Wealth Management's portfolio in Q3 2026, its #113 holding.
  • Cranbrook Wealth Management first reported a position in Idexx Laboratories in Q2 2024 and has held it in 10 quarters since.
  • Cranbrook Wealth Management's Idexx Laboratories position peaked at $413K in Q4 2025.
  • 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Cranbrook Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.